EcoDrugPlus

Acetylcholinesterase (Cartwright Blood Group)

Ensembl ID : ENSELUG00000010445
Gene Symbol: ACHE
3 Cross references
234 Possible Orthologues:

Activin A Receptor Type 2b

Ensembl ID : ENSELUG00000006178
Gene Symbol: ACVR2B
3 Cross references
196 Possible Orthologues:

Activin A Receptor Type 2b

Ensembl ID : ENSELUG00000018293
Gene Symbol: ACVR2B
3 Cross references
194 Possible Orthologues:

Adenosine A1 Receptor

Ensembl ID : ENSELUG00000019846
Gene Symbol: ADORA1
3 Cross references
208 Possible Orthologues:

Adenosine A2a Receptor

Ensembl ID : ENSELUG00000010092
Gene Symbol: ADORA2A
4 Cross references
200 Possible Orthologues:

Adenosine A2a Receptor

Ensembl ID : ENSELUG00000001844
Gene Symbol: ADORA2A
3 Cross references
188 Possible Orthologues:

Adenosine Deaminase

Ensembl ID : ENSELUG00000006483
Gene Symbol: ADA
3 Cross references
219 Possible Orthologues:

Adenosine Receptor A1

Ensembl ID : ENSELUG00000014300
Gene Symbol: LOC105023759
3 Cross references
201 Possible Orthologues:

Adenosine Receptor A1

Ensembl ID : ENSELUG00000023455
Gene Symbol: LOC105008641
2 Cross references
236 Possible Orthologues:

Adrenoceptor Alpha 1b

Ensembl ID : ENSELUG00000021602
Gene Symbol: ADRA1B
3 Cross references
194 Possible Orthologues:

Adrenoceptor Alpha 1d

Ensembl ID : ENSELUG00000003758
Gene Symbol: ADRA1D
3 Cross references
195 Possible Orthologues:

Adrenoceptor Alpha 2a

Ensembl ID : ENSELUG00000023041
Gene Symbol: ADRA2A
3 Cross references
176 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).